Targeting SARS-CoV-2 main protease for treatment of COVID-19: covalent inhibitors structure–activity relationship insights and evolution perspectives

G La Monica, A Bono, A Lauria… - Journal of medicinal …, 2022 - ACS Publications
The viral main protease is one of the most attractive targets among all key enzymes involved
in the SARS-CoV-2 life cycle. Covalent inhibition of the cysteine145 of SARS-CoV-2 MPRO …

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

X Li, Y Song - European Journal of Medicinal Chemistry, 2023 - Elsevier
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) identified in 2003
infected∼ 8000 people in 26 countries with 800 deaths, which was soon contained and …

Recent advances in SARS-CoV-2 main protease inhibitors: from nirmatrelvir to future perspectives

A Citarella, A Dimasi, D Moi, D Passarella, A Scala… - Biomolecules, 2023 - mdpi.com
The main protease (Mpro) plays a pivotal role in the replication of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target …

Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1

M Meyers, S Cismoski, A Panidapu… - ACS chemical …, 2024 - ACS Publications
Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating
proteins. Thus far, most heterobifunctional proteolysis targeting chimeras (PROTACs) have …

SARS-CoV-2 Mpro Inhibitors: Achieved Diversity, Developing Resistance and Future Strategies

C Fischer, JR Feys - Future Pharmacology, 2023 - mdpi.com
While the COVID-19 pandemic seems to be on its decline, the unclear impacts of long-
COVID cases, breakthrough infections in immunocompromised individuals, vaccine …

Large library docking for novel SARS‐CoV‐2 main protease non‐covalent and covalent inhibitors

EA Fink, C Bardine, S Gahbauer, I Singh… - Protein …, 2023 - Wiley Online Library
Antiviral therapeutics to treat SARS‐CoV‐2 are needed to diminish the morbidity of the
ongoing COVID‐19 pandemic. A well‐precedented drug target is the main viral protease …

Molecular docking via quantum approximate optimization algorithm

QM Ding, YM Huang, X Yuan - Physical Review Applied, 2024 - APS
Molecular docking plays a pivotal role in drug discovery and precision medicine, furnishing
insights into protein functionalities and fostering the development of therapeutics. Here, we …

On the origins of SARS-CoV-2 main protease inhibitors

YL Janin - RSC Medicinal Chemistry, 2024 - pubs.rsc.org
In order to address the world-wide health challenge caused by the COVID-19 pandemic, the
3CL protease/SARS-CoV-2 main protease (SARS-CoV-2-Mpro) coded by its nsp5 gene …

Synthesis and Preliminary Anti-Inflammatory and Anti-Microbial Evaluation of New 4, 5-Dihydro-1H-Pyrazole Derivatives

S Kanaan, TNA Omar - … Sciences (P-ISSN 1683-3597 E …, 2023 - bijps.uobaghdad.edu.iq
Organic compounds with pyrazole cores have a variety of uses, notably in the
pharmaceutical and agrochemical sectors. The interest in creating pyrazole compounds …

[PDF][PDF] POUR LE DIPLOME D'ETAT DE DOCTEUR EN PHARMACIE

MB Lucile - 2023 - pepite-depot.univ-lille.fr
Les coronavirus sont une vaste famille de virus à ARN capables d'infecter de nombreuses
espèces d'oiseaux et de mammifères, dont l'Homme. Au total, sept coronavirus peuvent …